Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is 69.42% vs 44.09% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is 335.92% vs 76.84% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is 431.97% vs 41.99% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is 15.26% vs 34.59% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
Compare Quarterly Results Of Nxera Pharma Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is 44.92% vs 15.00% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 69.42% vs 44.09% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 123.22% vs -361.78% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 335.92% vs 76.84% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is 1,739.93% vs 88.12% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 431.97% vs 41.99% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is -95.02% vs 2,725.49% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 15.26% vs 34.59% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






